Hélène Sabatel
Direttore/Membro del Consiglio presso DeuterOncology SA
Posizioni attive di Hélène Sabatel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
DeuterOncology SA
 DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Hélène Sabatel
Statistiche
Distribuzione geografica
| Belgio | 2 |
Posizioni
| Director/Board Member | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Health Technology |
- Borsa valori
- Insiders
- Hélène Sabatel
- Esperienza
